As of 2025-07-01, the Relative Valuation of MEDNAX Inc (MD) is (24.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.33 USD, the upside of MEDNAX Inc based on Relative Valuation is -273.0%.
The range of the Relative Valuation is (24.97) - (21.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.0x - 33.5x | 29.4x |
| Forward P/E multiples | 22.0x - 22.9x | 22.4x |
| Fair Price | (24.97) - (21.99) | (24.78) |
| Upside | -274.2% - -253.5% | -273.0% |
| Date | P/E |
| 2025-07-01 | -15.08 |
| 2025-06-30 | -14.97 |
| 2025-06-27 | -14.63 |
| 2025-06-26 | -14.22 |
| 2025-06-25 | -14.22 |
| 2025-06-24 | -14.06 |
| 2025-06-23 | -13.95 |
| 2025-06-20 | -13.79 |
| 2025-06-18 | -13.92 |
| 2025-06-17 | -13.99 |
| 2025-06-16 | -14.41 |
| 2025-06-13 | -14.60 |
| 2025-06-12 | -14.86 |
| 2025-06-11 | -14.83 |
| 2025-06-10 | -14.73 |
| 2025-06-09 | -14.74 |
| 2025-06-06 | -14.70 |
| 2025-06-05 | -14.52 |
| 2025-06-04 | -14.50 |
| 2025-06-03 | -14.39 |
| 2025-06-02 | -14.12 |
| 2025-05-30 | -14.76 |
| 2025-05-29 | -14.84 |
| 2025-05-28 | -14.31 |
| 2025-05-27 | -14.45 |
| 2025-05-23 | -14.14 |
| 2025-05-22 | -14.57 |
| 2025-05-21 | -15.82 |
| 2025-05-20 | -15.81 |
| 2025-05-19 | -15.51 |
| 2025-05-16 | -15.57 |
| 2025-05-15 | -15.52 |
| 2025-05-14 | -14.80 |
| 2025-05-13 | -15.04 |
| 2025-05-12 | -14.98 |
| 2025-05-09 | -15.16 |
| 2025-05-08 | -15.06 |
| 2025-05-07 | -14.97 |
| 2025-05-06 | -15.10 |
| 2025-05-05 | -13.51 |
| 2025-05-02 | -13.50 |
| 2025-05-01 | -13.29 |
| 2025-04-30 | -13.43 |
| 2025-04-29 | -13.10 |
| 2025-04-28 | -12.89 |
| 2025-04-25 | -12.78 |
| 2025-04-24 | -13.04 |
| 2025-04-23 | -12.80 |
| 2025-04-22 | -12.66 |
| 2025-04-21 | -12.52 |